Skip to main content
An official website of the United States government

autologous anti-FGFR4 CAR T cells

A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen receptor (CAR) targeting human fibroblast growth factor receptor 4 (FGFR4), with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-FGFR4 CAR T cells recognize and induce selective toxicity in FGFR4-expressing tumor cells. FGFR4, a receptor tyrosine kinase, is involved in angiogenesis and in the proliferation, differentiation, and survival of tumor cells.
Synonym:autologous anti-FGFR4 CAR-T cells
autologous FGFR4-CAR T cells
Search NCI's Drug Dictionary